According to BELLUS Health's latest financial reports the company's current revenue (TTM) is $0.01 M. In 2022 the company made a revenue of $0.01 M a decrease over the years 2021 revenue that were of $0.01 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.01 M | -6.25% |
2022 | $0.01 M | 0% |
2021 | $0.01 M | 6.67% |
2020 | $0.01 M | |
2018 | $0.01 M | -80.85% |
2017 | $0.1 M | -90.61% |
2016 | $1.08 M | -51.34% |
2015 | $2.23 M | 21.2% |
2014 | $1.84 M | -9.48% |
2013 | $2.03 M | -10.66% |
2012 | $2.27 M | -26.57% |
2011 | $3.1 M | 32.46% |
2010 | $2.34 M | -2271.1% |
2009 | -$0.11 M | -119.97% |
2008 | $0.54 M | -62.35% |
2007 | $1.43 M | -39.74% |
2006 | $2.38 M | 1.92% |
2005 | $2.33 M | |
2002 | $0.48 M | -88.49% |
2001 | $4.24 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |